Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2

Hepatitis C virus (HCV)-related chronic hepatitis is characterized by different clinical outcomes as well as by distinct biochemical and virological patterns. According to guidelines concerning dual therapy, high rates of sustained virological response (or HCV-RNA undetectable 24 weeks after the end...

Full description

Bibliographic Details
Main Authors: Elena Garlatti Costa, Michela Ghersetti, Silvia Grazioli, Pietro Casarin
Format: Article
Language:English
Published: PAGEPress Publications 2015-03-01
Series:Italian Journal of Medicine
Subjects:
Online Access:http://www.italjmed.org/index.php/ijm/article/view/471